487 related articles for article (PubMed ID: 24140055)
1. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
[TBL] [Abstract][Full Text] [Related]
3. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
[TBL] [Abstract][Full Text] [Related]
4. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
Meuleman P; Leroux-Roels G
Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
[TBL] [Abstract][Full Text] [Related]
6. Chimeric mouse model for the infection of hepatitis B and C viruses.
Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
[TBL] [Abstract][Full Text] [Related]
7. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
8. Novel hepatitis B virus infection mouse model using herpes simplex virus type 1 thymidine kinase transgenic mice.
Kanbe A; Ishikawa T; Hara A; Suemizu H; Nanizawa E; Tamaki Y; Ito H
J Gastroenterol Hepatol; 2021 Mar; 36(3):782-789. PubMed ID: 32515517
[TBL] [Abstract][Full Text] [Related]
9. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.
Douglas DN; Kawahara T; Sis B; Bond D; Fischer KP; Tyrrell DL; Lewis JT; Kneteman NM
PLoS One; 2010 Feb; 5(2):e9209. PubMed ID: 20174638
[TBL] [Abstract][Full Text] [Related]
11. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
[TBL] [Abstract][Full Text] [Related]
12. Animal model for study of human hepatitis viruses.
Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
[TBL] [Abstract][Full Text] [Related]
13. A novel cDNA-uPA/SCID/Rag2
Uchida T; Teraoka Y; Imamura M; Abe-Chayama H; Makokha GN; Hayes CN; Aikata H; Hamamura S; Ishida Y; Tateno C; Shirouzu T; Kawai S; Tanaka Y; Ohdan H; Okada S; Chayama K
J Viral Hepat; 2023 Mar; 30(3):262-272. PubMed ID: 36575861
[TBL] [Abstract][Full Text] [Related]
14. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
[TBL] [Abstract][Full Text] [Related]
15. Generation of humanized liver mouse model by transplant of patient-derived fresh human hepatocytes.
Kim M; Choi B; Joo SY; Lee H; Lee JH; Lee KW; Lee S; Park JB; Lee SK; Kim SJ
Transplant Proc; 2014 May; 46(4):1186-90. PubMed ID: 24815156
[TBL] [Abstract][Full Text] [Related]
16. Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.
Uchida T; Hiraga N; Imamura M; Tsuge M; Abe H; Hayes CN; Aikata H; Ishida Y; Tateno C; Yoshizato K; Ohdan H; Murakami K; Chayama K
J Virol; 2015 Oct; 89(19):10087-96. PubMed ID: 26246560
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
[TBL] [Abstract][Full Text] [Related]
18. Development of humanized mice for the study of hepatitis C virus infection.
Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
[TBL] [Abstract][Full Text] [Related]
19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
